| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/17/2003 | US20030073180 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073179 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073178 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073177 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073176 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073175 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073174 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073173 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073172 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/17/2003 | US20030073171 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073170 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073169 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030073168 Polypeptide for use in the diagnosis, treatment and prevention of cardiovascular diseases |
| 04/17/2003 | US20030073167 DNA encoding SNORF36 receptors |
| 04/17/2003 | US20030073166 Haemophilus adherence and penetration proteins |
| 04/17/2003 | US20030073163 Libraries of expressible gene sequences |
| 04/17/2003 | US20030073162 Protein for use in the diagnosis, treatment and prevention of cancer |
| 04/17/2003 | US20030073161 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and immunological disorders |
| 04/17/2003 | US20030073160 Compositions and methods for detecting stress-inducible proteins |
| 04/17/2003 | US20030073159 Nucleotide sequences coding polypeptide for use in the treatment of tumors and viral diseases |
| 04/17/2003 | US20030073154 Therapeutic agents that inhibit the TUP1 pathway |
| 04/17/2003 | US20030073144 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 04/17/2003 | US20030073143 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders and alzheimer's |
| 04/17/2003 | US20030073141 Monoclonal antibodies against a complex of human ACT and a serine protease |
| 04/17/2003 | US20030073137 Periostin-based diagnostic assays |
| 04/17/2003 | US20030073132 Detecting modulators of brain membrane protein; obtain membrane protein, incubate with ligand and labeled compound, measure level of binding |
| 04/17/2003 | US20030073131 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders |
| 04/17/2003 | US20030073130 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders |
| 04/17/2003 | US20030073129 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders |
| 04/17/2003 | US20030073120 Nucleotide sequences coding polypeptide for use in the treatment of signal tranduction defects |
| 04/17/2003 | US20030073117 Novel protein and gene encoding the protein |
| 04/17/2003 | US20030073115 Regulation of human galanin receptor-like g protein coupled receptor |
| 04/17/2003 | US20030073099 Novel nucleic acids and polypeptides |
| 04/17/2003 | US20030073095 Nucleotide sequences coding bacterial protein for use in the treatment and prevention of bacterial infections |
| 04/17/2003 | US20030073094 Stress proteins and uses therefor |
| 04/17/2003 | US20030073092 Modeling framework for predicting the number, type, and distribution of crossovers in directed evolution experiments |
| 04/17/2003 | US20030073090 Nucleotide sequences for use in the diagnosis, prevention and treatment of cell proliferative, tumor and nervous system disorders |
| 04/17/2003 | US20030073084 ING-encoded p33ING1 protein as a mediator of p53 signaling pathway in mammalian cells |
| 04/17/2003 | US20030073080 Genetically engineered viral nucleotide sequences for use as tool in gene therapy and vaccine development |
| 04/17/2003 | US20030073079 Nucleotide sequences for use in the diagnosis, prevention and treatment of cell proliferative, skin and tumor disorders |
| 04/17/2003 | US20030073077 Nucleotide sequences for use in the diagnosis, prevention and treatment of cell proliferative, skin and tumor disorders |
| 04/17/2003 | US20030073076 Analyzing modulators or treatments of fibroproliferative diseases; obtain sample, incubate with modulator, monitor marker expression, decreased expression indicate effective modulator |
| 04/17/2003 | US20030073072 Chimeric adenoviruses |
| 04/17/2003 | US20030073070 Measurement of protein s activity in sample; obtain sample, monitor clotting time, compare to control, evaluate protein s activity |
| 04/17/2003 | US20030073042 Process and materials for formation of patterned films of functional materials |
| 04/17/2003 | US20030072938 Trans-lentiviral vector particles and transduction of eukaryotic cells therewith |
| 04/17/2003 | US20030072796 For activating T lymphocytes in vitro for the treatment of disease conditions |
| 04/17/2003 | US20030072773 Vaccines |
| 04/17/2003 | US20030072772 Sub-unit vaccine for infectious pancreatic necrosis virus |
| 04/17/2003 | US20030072771 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142 |
| 04/17/2003 | US20030072769 Used in the manufacture of vaccines, therapy, prophylaxis, drug screening |
| 04/17/2003 | US20030072767 Compositions and methods for WT1 specific immunotherapy |
| 04/17/2003 | US20030072766 Comprising antiserum raised against a flagellaless Campylobacter strain for prophylaxis of Campylobacter colonisation in animals |
| 04/17/2003 | US20030072765 For therapy and prophylaxis of bacterial infections |
| 04/17/2003 | US20030072759 Administering to a patient afflicted with a gastrointestinal tumor, a murine monoclonal antibody which specifically binds to an epitope of 17-1A antigen, the antibody being administered parenterally in multiple doses |
| 04/17/2003 | US20030072755 Administering antibody to a protein component or to a carbohydrate-protein component of P-selectin glycoprotein ligand for therapy of rheumatoid arthritis |
| 04/17/2003 | US20030072753 Virus-like particles for the induction of autoantibodies |
| 04/17/2003 | US20030072752 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/17/2003 | US20030072745 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030072742 Enhancement of immune response using targeting molecules |
| 04/17/2003 | US20030072737 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 04/17/2003 | US20030072736 Human tumor necrosis factor receptor TR16 |
| 04/17/2003 | US20030072718 Spray drying to produce stable, high-potency dry powder formulations; utility in pulmonary delivery of interferons |
| 04/17/2003 | US20030071835 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030071834 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/17/2003 | US20030071418 Method and device for playing an improved game of blackjack |
| 04/17/2003 | CA2718802A1 Recombinant nucleic acids comprising regions of ad6 |
| 04/17/2003 | CA2463556A1 Methods for growing and imprinting fish using an odorant |
| 04/17/2003 | CA2463553A1 Gastrointestinal chemosensory receptors |
| 04/17/2003 | CA2463527A1 Love variant regulator molecules |
| 04/17/2003 | CA2462900A1 Reagents and methods useful for detecting diseases of the breast |
| 04/17/2003 | CA2462892A1 Human 3 relaxin |
| 04/17/2003 | CA2462873A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | CA2462687A1 Novel class ii cytokine receptor |
| 04/17/2003 | CA2462291A1 Methods and compositions for treating dermal lesions |
| 04/17/2003 | CA2462185A1 Methods for modulating activity of the fxr nuclear receptor |
| 04/17/2003 | CA2461900A1 Leukocyte inactivation module |
| 04/17/2003 | CA2461824A1 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 04/17/2003 | CA2461655A1 Nogo receptor-mediated blockade of axonal growth |
| 04/17/2003 | CA2461429A1 Peptides and related compounds having thrombopoietic activity |
| 04/17/2003 | CA2461343A1 Mammalian c-type lectins |
| 04/17/2003 | CA2461315A1 Toll-like receptor 3 signaling agonists and antagonists |
| 04/17/2003 | CA2460625A1 Structural and cytoskeleton-associated proteins |
| 04/17/2003 | CA2460480A1 Molecules for disease detection and treatment |
| 04/17/2003 | CA2460476A1 Protein modification and maintenance molecules |
| 04/17/2003 | CA2458645A1 Intracellular signaling molecules |
| 04/17/2003 | CA2457565A1 Novel acidic mammalian proteins and polynucleotides encoding the same |
| 04/17/2003 | CA2426384A1 Antibody inhibiting vplf activity |
| 04/16/2003 | EP1302542A1 Novel physiologically active peptide and use thereof |
| 04/16/2003 | EP1302541A1 Receptor protein specifically recognizing bacterial dna |
| 04/16/2003 | EP1302539A1 Tumor-specific promoters |
| 04/16/2003 | EP1302477A1 Peptide fructose and complex thereof with binding protein |
| 04/16/2003 | EP1302206A1 Methods and means for the use of the adventitial toll-like receptor |
| 04/16/2003 | EP1302104A1 P300 transgenic animal |
| 04/16/2003 | EP1301795A2 Method of identifying and/or isolating stem cells |
| 04/16/2003 | EP1301786A1 Method for the detection of apoptosis by determining apoptosis-specific markers released into an extracellular medium through cellular release mechanisms |
| 04/16/2003 | EP1301637A2 Dna vaccines encoding hiv accessory proteins |
| 04/16/2003 | EP1301636A1 Method for determining three-dimensional protein structure from primary protein sequence |
| 04/16/2003 | EP1301624A2 Preprocalcitonin as tumor rejection antigen precursor and uses thereof |
| 04/16/2003 | EP1301616A2 Bicistronic influenza viruses comprising two genes in tandem |